Results 101 to 110 of about 10,266 (173)

Cohort retention in seasonal malaria chemoprevention: an analysis of magnitude and associated factors in Northern Bahr el Ghazal, South Sudan

open access: yesFrontiers in Malaria
BackgroundHealth interventions that require multi-dose regimens are most effective when all doses are taken. Adherence to a full three-day course of Sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) in all planned cycles of the annual seasonal malaria ...
Francis Okot   +12 more
doaj   +1 more source

Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria

open access: yesBulletin of the World Health Organization
OBJECTIVE: To test a novel methodology to define age-based dosing regimens for the treatment of malaria with a new, user-friendly, blister-packaged fixed-dose combination of artesunate and amodiaquine.
Walter RJ Taylor   +5 more
doaj   +1 more source

Interactions between DNA purinic bases and amodiaquine: A theoretical approach

open access: yes, 2009
We study theoretically the amodiaquine-adenine and amodiaquine-guanine adducts formation using Density Functional Theory (B3LYP) and the 6-31G(d) basis set for the geometry optimizations and 6-31+G(d,p) for the analysis of the global indexes ...
Lacerda Júnior, Valdemar   +3 more
core  

Correlation of amodiaquine sensitivity to chloroquine and quinine against Plasmodium falciparum in vitro

open access: yes, 1998
Amodiaquine, a 4-aminoquinoline derivative has been introduced since decades ago, and yet the, use remains debatable for its side effects. Chioroquine, the least side effect of antimalarials possessing similarity in pharmacokinetic properties has been ...
Perpustakaan UGM, i-lib
core   +1 more source

Voacanga africana-artesunate and Voacanga africana-amodiaquine combinations as effective anti-plasmodial agents in mice

open access: yesScientific African
Background: Malaria is a global health problem due to its high incidence of morbidity and mortality, especially in children and pregnant women. However, the Plasmodium parasite frequently develops resistance to chemotherapy, triggering continuous ...
Daniel Ampomah Frimpong   +6 more
doaj   +1 more source

Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo

open access: yesMemorias do Instituto Oswaldo Cruz, 2007
Resistance in Plasmodium falciparum to amodiaquine (AQ) can be reversed in vitro with with antihistaminic and tricyclic antidepressant compounds, but its significance in vivo is unclear.
Akintunde Sowunmi   +7 more
doaj  

Isoquine and related amodiaquine analogues: A new generation of improved 4-aminoquinoline antimalarials

open access: yes, 2003
Amodiaquine (AQ) (2) is a 4-aminoquinoline antimalarial that can cause adverse side effects including agranulocytosis and liver damage. The observed drug toxicity is believed to involve the formation of an electrophilic metabolite, amodiaquine ...
Bickley, Jamie F.   +27 more
core   +1 more source

Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections

open access: yesCPT: Pharmacometrics & Systems Pharmacology
Artemisinin‐based combination therapy (ACT) is the first‐line recommended treatment for uncomplicated malaria. Pharmacokinetic (PK) properties in pregnant women are often based on small studies and need to be confirmed and validated in larger pregnant ...
Junjie Ding   +13 more
doaj   +1 more source

Correlation of amodiaquine sensitivity to chioroquine and quinine against plasmodium falciparum In Vitro

open access: yes, 2015
Amodiaquine, a 4-aminoquinoline derivative has been introduced since decades ago, and yet the. use remains debatable for its side effects. Chioroquine, the least side effect of antimalarials possessing similarity in pharmacokinetic properties has been ...
Soesanto Tjokrosonto, Soesanto Tjokrosonto
core  

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon

open access: yesBulletin of the World Health Organization, 2002
OBJECTIVE: To evaluate the therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine, and the sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco Leonardo K.   +6 more
doaj  

Home - About - Disclaimer - Privacy